These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9535490)

  • 21. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
    Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
    Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ventricular arrhythmias in ion channel diseases].
    Wolpert C; Vogel M; Nagel C; Herrera-Siklody C; Rüb N
    Herzschrittmacherther Elektrophysiol; 2017 Jun; 28(2):169-176. PubMed ID: 28534204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators.
    Pires LA; May LM; Ravi S; Parry JT; Lal VR; Nino CL
    Am J Cardiol; 2000 Mar; 85(6):725-8. PubMed ID: 12000047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical application of the fibrillation number in patients with an implantable cardioverter defibrillator.
    Hwang M; Lee H; Lee YS; Chung S; Choi SH; Shim EB; Pak HN
    Prog Biophys Mol Biol; 2014 Sep; 116(1):33-9. PubMed ID: 25236363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined third-generation implantable cardioverter defibrillator with permanent unipolar pacemakers: preliminary observations.
    Haffajee C; Casavant D; Desai P; Moon R; Voukydis P; Pacetti P
    Pacing Clin Electrophysiol; 1996 Feb; 19(2):136-42. PubMed ID: 8834682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator.
    Grimm W; Flores BF; Marchlinski FE
    Am J Cardiol; 1993 Jun; 71(16):1415-8. PubMed ID: 8517386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is ventricular fibrillation undersensing?
    Brown ML
    J Electrocardiol; 2018; 51(6S):S35-S37. PubMed ID: 30197160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations of heart rate variability parameters prior to the onset of ventricular tachyarrhythmia and sinus tachycardia in ICD patients. Results from the heart rate variability analysis with automated ICDs (HAWAI) registry.
    Wollmann CG; Gradaus R; Böcker D; Fetsch T; Hintringer F; Hoh G; Hatala R; Podczeck-Schweighofer A; Kreutzer U; Kamaryt P; Hauser T; Kersten JF; Wegscheider K; Breithardt G
    Physiol Meas; 2015 May; 36(5):1047-61. PubMed ID: 25903155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial clinical experience with a new arrhythmia detection algorithm in dual chamber implantable cardioverter defibrillators.
    Theuns D; Klootwijk AP; Kimman GP; Szili-Török T; Roelandt JR; Jordaens L
    Europace; 2001 Jul; 3(3):181-6. PubMed ID: 11467458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure to detect life-threatening arrhythmias in ICDs using single-chamber detection criteria.
    Stroobandt RX; Duytschaever MF; Strisciuglio T; Van Heuverswyn FE; Timmers L; De Pooter J; Knecht S; Vandekerckhove YR; Kucher A; Tavernier RH
    Pacing Clin Electrophysiol; 2019 Jun; 42(6):583-594. PubMed ID: 30657188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Raitt MH; Klein RC; Wyse DG; Wilkoff BL; Beckman K; Epstein AE; Coromilas J; Friedman PL; Martins J; Ledingham RB; Greene HL;
    Am J Cardiol; 2003 Apr; 91(7):812-6. PubMed ID: 12667566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Shockable Ventricular Arrhythmia using Variational Mode Decomposition.
    Tripathy RK; Sharma LN; Dandapat S
    J Med Syst; 2016 Apr; 40(4):79. PubMed ID: 26798076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical investigation of a new dual-chamber implantable cardioverter defibrillator with improved rhythm discrimination capabilities.
    Bailin SJ; Niebauer M; Tomassoni G; Leman R;
    J Cardiovasc Electrophysiol; 2003 Feb; 14(2):144-9. PubMed ID: 12693494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.
    Zareba W; Daubert JP; Beck CA; Huang DT; Alexis JD; Brown MW; Pyykkonen K; McNitt S; Oakes D; Feng C; Aktas MK; Ayala-Parades F; Baranchuk A; Dubuc M; Haigney M; Mazur A; McPherson CA; Mitchell LB; Natale A; Piccini JP; Raitt M; Rashtian MY; Schuger C; Winters S; Worley SJ; Ziv O; Moss AJ;
    J Am Coll Cardiol; 2018 Aug; 72(6):636-645. PubMed ID: 30071993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of Electromechanical Coupling to Prevent Inappropriate Implantable Cardioverter-Defibrillator Shocks.
    Keene D; Shun-Shin MJ; Arnold AD; Howard JP; Lefroy D; Davies DW; Lim PB; Ng FS; Koa-Wing M; Qureshi NA; Linton NWF; Shah JS; Peters NS; Kanagaratnam P; Francis DP; Whinnett ZI
    JACC Clin Electrophysiol; 2019 Jun; 5(6):705-715. PubMed ID: 31221358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do atrial tachyarrhythmias beget ventricular tachyarrhythmias in defibrillator recipients?
    Stein KM; Euler DE; Mehra R; Seidl K; Slotwiner DJ; Mittal S; Markowitz SM; Lerman BB;
    J Am Coll Cardiol; 2002 Jul; 40(2):335-40. PubMed ID: 12106941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
    Rosenthal TM; Stahls PF; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Xue JQ; Morin DP
    Heart Rhythm; 2015 Aug; 12(8):1789-97. PubMed ID: 25998895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Results of delivered therapy for VT or VF in patients with third-generation implantable cardioverter defibrillators.
    Rabinovich R; Muratore C; Iglesias R; Gonzalez M; Serafrica M; Sosa Liprandi A
    Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):133-6. PubMed ID: 7724386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.